TrialBioMed research international2015

A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors.

Zhengzi Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.